PetMed Express (NASDAQ:PETS) Stock Price Crosses Above Two Hundred Day Moving Average - What's Next?

PetMed Express, Inc. (NASDAQ:PETS - Get Free Report)'s stock price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $3.93 and traded as high as $4.61. PetMed Express shares last traded at $4.53, with a volume of 122,732 shares changing hands.

Analyst Upgrades and Downgrades

PETS has been the subject of several analyst reports. Lake Street Capital reissued a "hold" rating and set a $3.50 target price (down from $7.00) on shares of PetMed Express in a research note on Wednesday, August 7th. StockNews.com raised PetMed Express from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th.

PetMed Express Trading Up 2.0 %

The firm's fifty day moving average is $4.09 and its 200 day moving average is $3.94. The stock has a market cap of $95.45 million, a P/E ratio of -77.33 and a beta of 0.68.

PetMed Express (NASDAQ:PETS - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.11 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.17. The firm had revenue of $59.57 million during the quarter, compared to the consensus estimate of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. Research analysts forecast that PetMed Express, Inc. will post 0.24 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, major shareholder Nina Capital Holdings Inc. purchased 12,500 shares of PetMed Express stock in a transaction that occurred on Monday, September 9th. The stock was bought at an average price of $3.34 per share, for a total transaction of $41,750.00. Following the completion of the transaction, the insider now owns 2,078,000 shares in the company, valued at $6,940,520. This represents a 0.61 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.10% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Sei Investments Co. increased its position in shares of PetMed Express by 8.3% during the 2nd quarter. Sei Investments Co. now owns 44,220 shares of the company's stock valued at $179,000 after purchasing an additional 3,400 shares during the last quarter. Point72 DIFC Ltd purchased a new position in shares of PetMed Express in the second quarter worth about $34,000. Vanguard Group Inc. raised its position in PetMed Express by 0.8% during the first quarter. Vanguard Group Inc. now owns 1,186,485 shares of the company's stock valued at $5,683,000 after acquiring an additional 9,226 shares in the last quarter. Marshall Wace LLP purchased a new stake in shares of PetMed Express in the second quarter valued at approximately $46,000. Finally, SG Americas Securities LLC acquired a new position in PetMed Express during the second quarter worth $46,000. 73.33% of the stock is owned by hedge funds and other institutional investors.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.